Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107).

Blood
Nikolas von BubnoffJustus Duyster

Abstract

In advanced-phase chronic myeloid leukemia (CML), resistance to imatinib mesylate is associated with point mutations in the BCR-ABL kinase domain. A new generation of potent ABL kinase inhibitors is undergoing clinical evaluation. It is important to generate specific resistance profiles for each of these compounds, which could translate into combinatorial and sequential treatment strategies. Having characterized nilotinib (AMN107) against a large panel of imatinib mesylate-resistant Bcr-Abl mutants, we investigated which mutants might arise under nilotinib therapy using a cell-based resistance screen. In contrast to imatinib mesylate, resistance to nilotinib was associated with a limited spectrum of Bcr-Abl kinase mutations. Among these were mutations affecting the P-loop and T315I. Rarely emerging resistant colonies at a concentration of 400 nM nilotinib exclusively expressed the T315I mutation. With the exception of T315I, all of the mutations that were identified were effectively suppressed when the nilotinib concentration was increased to 2000 nM, which falls within the peak-trough range in plasma levels (3.6-1.7 microM) measured in patients treated with 400 mg twice daily. Our findings suggest that nilotinib might be super...Continue Reading

References

Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J DuysterJ Y Wang
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Jun 5, 2003·Seminars in Hematology·Andreas Hochhaus
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bin PengRenaud Capdeville
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Feb 16, 2005·Cancer Cell·Ellen WeisbergJames D Griffin
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Jul 15, 2005·The New England Journal of Medicine·Jin-Yuan ShihPan-Chyr Yang

❮ Previous
Next ❯

Citations

May 1, 2007·Current Hematologic Malignancy Reports·Ronan SwordsFrancis J Giles
Sep 6, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Anthony M Ford, Angel Martínez-Ramírez
Apr 4, 2009·International Journal of Hematology·Masahide YamamotoHisashi Sakamaki
Jul 14, 2010·Oncogene·E WeisbergJ D Griffin
Nov 30, 2006·Current Opinion in Oncology·Markus WarmuthFrancisco Adrián
Dec 14, 2011·The Cancer Journal·David W WoessnerMichael W Deininger
Sep 25, 2012·Cancer Research·Oliver HantschelGiulio Superti-Furga
Nov 22, 2013·PloS One·Eliza VakanaLeonidas C Platanias
Aug 10, 2010·Core Evidence·Elias JabbourHagop Kantarjian
May 11, 2011·Cancer Management and Research·David L DeremerCelalettin Ustun
Nov 19, 2009·Drug Design, Development and Therapy·Ronan SwordsFrancis Giles
Nov 19, 2009·Drug Design, Development and Therapy·Carmen FavaElias Jabbour
Feb 14, 2014·Leukemia Research·Mohammad Reza Noori-DaloiiAli Reza Noori-Daloii
Oct 17, 2008·Future Oncology·Alfonso Quintás-Cardama, Jorge Cortes
Oct 31, 2008·American Journal of Physiology. Cell Physiology·Xin ZhengAbdelhadi Rebbaa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.